UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 9

of 'Oral isotretinoin therapy for acne vulgaris'

9
TI
A dose-response study of I3-cis-retinoic acid in acne vulgaris.
AU
Jones DH, King K, Miller AJ, Cunliffe WJ
SO
Br J Dermatol. 1983;108(3):333.
 
13-cis-retinoic acid has been used as a single agent in the treatment of seventy-six patients with previously unresponsive cystonodular acne. The study was carried out in a double-blind fashion using three doses of the drug. Ninety per cent of the patients responded with a 70% improvement in the acne severity. Sixty-six per cent of the patients experienced no further problems with their acne during follow-up. Side-effects were frequent. The 0.5 mg/kg b.w. dose is recommended for the initial course of treatment.
AD
PMID